WO2025006632A2 - Systèmes d'assistance cardiaque comprenant des pompes à sang à soupape mobile - Google Patents

Systèmes d'assistance cardiaque comprenant des pompes à sang à soupape mobile Download PDF

Info

Publication number
WO2025006632A2
WO2025006632A2 PCT/US2024/035655 US2024035655W WO2025006632A2 WO 2025006632 A2 WO2025006632 A2 WO 2025006632A2 US 2024035655 W US2024035655 W US 2024035655W WO 2025006632 A2 WO2025006632 A2 WO 2025006632A2
Authority
WO
WIPO (PCT)
Prior art keywords
check valve
movable check
pump
flexible conduit
heart assist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2024/035655
Other languages
English (en)
Other versions
WO2025006632A3 (fr
Inventor
Marlin S. Heilman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vascor Inc
Original Assignee
Vascor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vascor Inc filed Critical Vascor Inc
Publication of WO2025006632A2 publication Critical patent/WO2025006632A2/fr
Publication of WO2025006632A3 publication Critical patent/WO2025006632A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/20—Type thereof
    • A61M60/247—Positive displacement blood pumps
    • A61M60/253—Positive displacement blood pumps including a displacement member directly acting on the blood
    • A61M60/258—Piston pumps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/10—Location thereof with respect to the patient's body
    • A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
    • A61M60/126—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel
    • A61M60/13—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel by means of a catheter allowing explantation, e.g. catheter pumps temporarily introduced via the vascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/10—Location thereof with respect to the patient's body
    • A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
    • A61M60/126—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel
    • A61M60/135—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel inside a blood vessel, e.g. using grafting
    • A61M60/139—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel inside a blood vessel, e.g. using grafting inside the aorta, e.g. intra-aortic balloon pumps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/40—Details relating to driving
    • A61M60/424—Details relating to driving for positive displacement blood pumps
    • A61M60/438—Details relating to driving for positive displacement blood pumps the force acting on the blood contacting member being mechanical
    • A61M60/441—Details relating to driving for positive displacement blood pumps the force acting on the blood contacting member being mechanical generated by an electromotor
    • A61M60/443—Details relating to driving for positive displacement blood pumps the force acting on the blood contacting member being mechanical generated by an electromotor with means converting the rotation into a translational movement of the displacement member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/80—Constructional details other than related to driving
    • A61M60/855—Constructional details other than related to driving of implantable pumps or pumping devices
    • A61M60/861—Connections or anchorings for connecting or anchoring pumps or pumping devices to parts of the patient's body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
    • A61M60/80—Constructional details other than related to driving
    • A61M60/855—Constructional details other than related to driving of implantable pumps or pumping devices
    • A61M60/89—Valves
    • A61M60/894—Passive valves, i.e. valves actuated by the blood

Definitions

  • the American Heart Association estimates that 5.7 million Americans have heart failure.
  • the main muscle chamber of the heart is termed the left ventricle or LV.
  • the LV functions by periodically squeezing a portion of its blood content through its outlet aortic valve into the body’s aorta and arterial circulation.
  • the average blood flow for each LV contraction or stroke volume will be 5,000/72 or about ⁇ 70 milliliters (ml’s or cc’s) of blood.
  • this 70 ml stroke volume may be reduced ⁇ 50% to ⁇ 35 ml and the person’s body will suffer from serious heart failure that may be fatal.
  • a heart transplant may be curative for ten or more years. However, yearly only approximately 2,500 such transplantable hearts are available in the United States. Cardiac assist, heart assist, and/or ventricular assist devices or VADs are available to preserve life in approximately 8,000 US cases of severe heart failure per year.
  • a VAD is a device that helps pump blood from the lower chambers of the heart to the rest of the body.
  • HEARTMATE 3TM available from Abbott Laboratories of Abbott Park, Illinois
  • HEARTWARE HVAD® available from Medtronic of Fridley, MN
  • Both those VADs operate by receiving blood from the apex or tip of the LV and then pump this blood around the LV into the aorta, which is the body’s main artery just beyond the LV’s outlet aortic valve.
  • VADs require major surgery to gain access to both the apex or tip of the LV as well as to the aorta beyond the LV. Because these rotary VADs pump blood in parallel with and around the LV, higher rotary pump speeds have the risk of pumping the heart dry. The optimum pump speed allows blood to always flow naturally through the outlet aortic valve with each heartbeat and thereby avoid LV blood stagnation.
  • the pumping mechanism of both of those VADs includes a rotating impeller having metallic vanes that propel the blood against aortic pressure.
  • This abnormal (with respect to the manner in which blood is pumped via the heart) pumping action has side effects.
  • One side effect is the inevitable blood shear from the spinning impeller vanes damaging various blood elements including the von Willibrand factor and blood platelets leading to both the risk of abnormal blood clotting (strokes) and bleeding (gastrointestinal).
  • strokes blood clotting
  • gastrointestinal bleeding
  • VAD patients are strongly anticoagulated with coumadin and are then at risk of bleeding.
  • VAD patients also have an infection risk due to the skin piercing driveline in their abdominal wall. The driveline is necessary to power the VAD and power loss may be fatal.
  • managing VADs is complicated and there are many potential adverse events. It has been reported that nearly 70% of VAD patients have one or more serious adverse events or complications in their first implant year.
  • a moving valve pump has, for example, been attached to an in-chest motor. Using major surgery, that pump can be placed in series with the aorta. The motive force for the valve in that moving valve pump is supplied by an electro-magnetic motor. However, having the motor as a part of the moving valve pump requires open chest surgery for installation.
  • PCI percutaneous coronary interventions
  • Patients having an acute heart attack from a complete or near complete coronary artery obstruction frequently undergo percutaneous coronary interventions or PCI procedures.
  • PCI involves placing long thin tubes (catheters) through the skin and with X-ray imaging and injected fluid contrast media, attempting to open blocked coronary arteries to improve the blood supply to the heart’s muscle.
  • Cardiologists attempt to open these coronary artery obstructions with balloons and keep them open with stents.
  • a major risk of PCI is the possibility of converting a partly occluded coronary artery into a complete occlusion resulting in a sudden total blood flow blockage.
  • IMPELLA VADs are a family of small diameter catheters placed through the skin into the arterial system and through the aortic valve into the LV. The catheter pump is capable of moving blood from the LV through the aortic valve into the aorta.
  • the IMPELLA pumping mechanism is a miniature screw-like impeller inside the catheter, spinning at speeds from 20,000 to 50.000 revolutions per minute.
  • the most commonly used IMPELLA 2.5 can provide up to 2.5 liters per minute of blood flow from the LV and, in shock, this may be lifesaving.
  • use of an IMPELLA VAD is time limited to hours or at most days.
  • the IMPELLA 2.5 catheter pump has a 4 mm diameter and can be placed by the minimally invasive Seidinger technique including a needle skin puncture, guidewire insertion and then catheter placement over the guide wire.
  • the IMPELLA 5.5 can pump up to 5.5 liters per minute and is 6.33 mm or 19 French in diameter. Placement of the IMPELLA 5.5 catheter pump requires a “cut down” through the skin with direct visualization and incision in the right or left axillary/subclavian artery.
  • TAVAR valve replacement procedure has been developed to treat patients having stenosis or hardening of their aortic valve.
  • TAVAR valves Under fluoroscopic guidance and using a catheter, TAVAR valves are placed inside a patient’s defective aortic valve. The valve is expandable and becomes permanently expanded by, for example, a balloon. TAVAR valves have no pumping action but are check valves, allowing blood flow to flow only away from the LV into the aorta.
  • a linear, reciprocating valve pump has recently been described which is indicated to be suitable for implantation via the circulatory system of a patient to various positions for circulatory assist in stabilizing a patient to gain time for more long-term treatment.
  • a single valve which is driven by a single linear motor, reciprocates within an expandable housing such that a rim thereof may form a seal with and slides along the housing. Regardless of tolerances, such sliding contact can lead to damage of various blood elements including the von Willibrand factor and blood platelets leading to both the risk of abnormal blood clotting and bleeding as described above. Further, providing a gap between such a rim and the housing of the device can lead to significant inefficiencies in pumping.
  • FIG. 1 A illustrates the left axillary (underarm) body entrance location for a pump and catheter of an embodiment of temporary heart assist system hereof.
  • FIG. IB illustrates the location of the permanent implant configuration for a pump and drive system of the heart assist system hereof wherein the drive system (for example, a motor drive) is implanted subcutaneously in the lower left axillary region.
  • the drive system for example, a motor drive
  • FIG. 1C illustrates a right axillary artery (in the right subclavian region) body entrance location for a pump and heart assists system hereof which may provide an advantage of a less tortuous blood vessel pathway.
  • FIG. 2 A illustrates an embodiment of a heart assist pump hereof including two moving valves wherein the heart assist pump is compressed for insertion/removal.
  • FIG. 2B illustrates the pump of FIG. 2 A deployed/expanded after insertion, wherein an introduction sheath is used for pump compression and is retracted from the pump to allow expansion.
  • FIG. 3 A illustrates an embodiment including the pump of FIG. 2 A wherein the valves are driven by wire actuators.
  • FIG. 3B illustrates an embodiment of a torque DC motor wherein the motor’s rotor drives a crankshaft that includes two rotating bearings that are operatively connected to actuators to drive the valves in equal and opposite directions.
  • FIG. 4A illustrates a side view of an embodiment of the low flow slippage valve structure wherein five of the eight struts are shown, and wherein the struts can be compressed towards the pump’s central axis to reduce the diameter of the pump and held compressed by a compression sleave for insertion/withdrawal purposes.
  • FIG. 4B illustrates two axial, cross-sectional views (at different points on the axis of the valve) of the valve of FIG . 4A in the open state where the triangular shaped flaps are flexed, bent or curled to an open state.
  • FIG. 5 illustrates the position of a heart assist pump hereof with a distal tip of a chamber of the pump in the left ventricle and the body of the pump in the ascending aorta, wherein a bare wire stent is deployed against the inner wall of the ascending aortic wall for grounding purposes, and wherein the pump’s open wire stent allows aortic blood to flow backwards into the coronary' arteries.
  • a heart or circulation assist system includes a catheter and a pump connected to a distal end of the catheter.
  • the pump includes an outer flexible conduit, a first movable check valve attached to the outer flexible conduit about the perimeter of the first movable check valve, and a second movable check valve, which is spaced from and in series with the first movable check valve, attached to the outer flexible conduit about the perimeter of the second movable check valve.
  • the heart assist system further includes a drive system connected to the catheter and positioned remote from the first movable valve and the second movable check valve, a first actuator operatively connected to the drive system and to the first movable check valve via the catheter to transfer linear motion from the drive system to the first movable check valve, and a second actuator operatively connected to the drive system and to the second movable check valve via the catheter to transfer linear motion from the drive system to the second movable check valve.
  • the pump is collapsible to a first, smaller-radius state in which the pump is implantable within a body of a patient via the catheter and expandable to a second, larger-radius state after implanting via the catheter to an operational position within the body of the patient.
  • the first movable check valve may be attached to the outer flexible conduit to form a sealed attachment therewith and the second movable check valve is attached to the outer flexible conduit to form a sealed attachment therewith.
  • the heart assist system further includes an inner flexible conduit having a diameter less than the outer flexible conduit.
  • the first movable check valve may be attached to the inner flexible conduit at a position radially inward from the perimeter of the first movable check valve.
  • the first movable check valve may attached to the outer flexible conduit to form a sealed attachment therewith and may be attached to the inner flexible conduit to form a sealed attachment therewith.
  • the second movable check valve may be attached to the outer flexible conduit to form a sealed attachment therewith and may be attached to the inner flexible conduit to form a sealed attachment therewith.
  • the second movable check valve may be attached to the inner flexible conduit at a position radially inward from the perimeter of the second movable check valve.
  • the first actuator and the second actuator may, for example, pass through the catheter and into a volume within the inner flexible conduit.
  • Tire first actuator and the second actuator may, for example, independently include a wire or a tube.
  • the heart assist system further includes a guide wire conduit passing through the catheter and through the volume within the inner flexible conduit.
  • at least one of the outer flexible conduit and the inner flexible conduit includes extra material in an axial direction along the length thereof At least one of the outer flexible conduit and the inner flexible conduit may, for example, include corrugation or folds therein.
  • the heart assist system may further include an intake chamber at a distal end of the pump.
  • the intake chamber in a number of embodiments, incudes one or more passages at a distal end thereof though which blood may pass to enter the pump.
  • the intake chamber further includes a solid surface at a proximal end thereof configured to form a seal with the aortic valve.
  • the pump further includes a stent radially outward of the outer flexible conduit.
  • the stent contacts the aortic wall and provides a mechanical ground for the pump.
  • the drive system includes a motor.
  • the motor drives the first actuator and the second actuator such that the first movable check valve and the second movable check valve are driven sinusoidally in a number of embodiments.
  • the motor may, for example, drive the first actuator and the second actuator such that the first movable check valve and the second movable check valve are driven approximately 180 degrees out of phase.
  • the drive system comprises a crank shaft in operative connection with a rotor of the motor, wherein each of the first actuator and the second actuator are operatively connected to the crank shaft.
  • the drive system includes two drive arms positioned approximately 180 degrees apart around a drive axle in operative connection with the rotor of the motor, each of the first actuator and the second actuator being operatively connected to a different one of the drive arms.
  • the motor may, for example, be configured to be positioned outside of the body of the patient and the catheter may be configured to pass percutaneously into the body of the patient.
  • the motor may also or alternatively be configured to be positioned within the body of the patient and outside the chest cavity of the patient, and the catheter may be configured to be implanted within the body of the patient.
  • the first movable check valve in a number of embodiments, includes at least one element which closes a port formed in the first movable check valve upon motion of the first movable check valve to move blood.
  • the second movable check valve in a number of embodiments, includes at least one element which closes a port formed in the second movable check valve upon motion of the second movable check valve to move blood.
  • a method of assisting the function of the heart or circulation includes placing a heart assist system as described herein in connection with a patient’s circulatory system, hi a number of embodiments, the pump is positioned within the ascending aorta with a distal end of the pump extending into the left ventricle.
  • the method may include placing the heart assist system in fluid connection with the circulatory system of a patient at an operational position within the body of the patient via a catheter.
  • the heart assist system includes a pump connected to a distal end of the catheter.
  • the pump includes an outer flexible conduit, a first movable check valve attached to the outer flexible conduit about the perimeter of the first movable check valve, and a second movable check valve, which is spaced from and in series with the first movable check valve, attached to the outer flexible conduit about the perimeter of the second movable check valve.
  • the pump is collapsible.
  • the heart assist system further includes a drive system connected to the catheter and positioned remote from the first movable valve and the second movable check valve, a first actuator operatively connected to the drive system and to the first movable check valve via the catheter to transfer linear motion from the drive system to the first movable check valve, and a second actuator operatively connected to the drive system and to the second movable check valve via the catheter to transfer linear motion from the drive system to the second movable check valve.
  • the method further includes advancing the pump to the operational position while the pump is collapsed to a first, smaller-radius state; and expanding the pump to a second, larger-radius state after upon reaching the operational position.
  • a heart or circulatory assist pump is connected to a distal end of a catheter and includes an outer flexible conduit, a first movable check valve attached to the outer flexible conduit about the perimeter of the first movable check valve, and a second movable check valve, spaced from and in series with the first movable check valve, attached to the outer flexible conduit about the perimeter of the second movable check valve.
  • the heart assist pump further includes a first actuator operatively connected to the first movable check valve and configured to be connected to a drive system remote from the pump via the catheter to transfer linear motion from the drive system to the first movable check valve, and a second actuator operatively connected to the second movable check valve and configured to be connected to the drive system via the catheter to transfer linear motion from the drive system to the second movable check valve.
  • the pump is collapsible to a first, smaller-radius state in which the pump is implantable within a body of a patient via the catheter and expandable to a second, larger-radius state after implanting via the catheter to an operational position within the body of the patient.
  • Tire first movable check valve may be attached to the outer flexible conduit to form a sealed attachment therewith and the second movable check valve is attached to the outer flexible conduit to form a sealed attachment therewith.
  • the heart assist pump may further include an inner flexible conduit having a diameter less than the outer flexible conduit.
  • the first movable check valve being attached to the inner flexible conduit at a position radially inward from the perimeter of the first movable check valve.
  • the first movable check valve may attached to the outer flexible conduit to form a sealed attachment therewith and may be attached to the inner flexible conduit to form a sealed attachment therewith.
  • a method of assisting the function of the heart or circulation includes placing a pump as described herein in connection with a patient's circulatory' system.
  • the pump is positioned within the ascending aorta with a distal end of the pump extending into the left ventricle.
  • the method may include placing a heart assist pump in fluid connection with the circulatory system of a patient at an operational position within the body of the patient via a catheter.
  • the heart assist pump includes an outer flexible conduit, a first movable check valve attached to the outer flexible conduit about the perimeter of the first movable check valve, and a second movable check valve, spaced from and in series with the first movable check valve, attached to the outer flexible conduit about the perimeter of the second movable check valve, a first actuator operatively connected to the first movable check valve and configured to be connected to a drive system remote from the heart assist pump via the catheter to transfer linear motion from the drive system to the first movable check valve, and a second actuator operatively connected to the second movable check valve and configured to be connected to the drive system via the catheter to transfer linear motion from the drive system to the second movable check valve.
  • the heart assist pump is collapsible to a first, smaller-radius state in which the heart assist pump is implantable within the body of the patient via the catheter and expandable to a second, larger-radius state after implanting via the catheter to an operational position within the body of the patient.
  • the method further includes advancing the heart assist pump to the operational position through while the heart assist pump is collapsed to a first, smaller-radius state and expanding the heart pump to a second, larger-radius state after upon reaching the operational position.
  • a heart assist system in another aspect, includes a catheter, and a pump connected to a distal end of the catheter.
  • the pump includes an outer flexible conduit, a first movable check valve attached to the outer flexible conduit about the perimeter of the first movable check valve.
  • the heart assist system further include a drive system connected to the catheter and positioned remote from the first movable valve and the second movable check valve and a first actuator operatively connected to the drive system and to the first movable check valve via the catheter to transfer linear motion from the drive system to the first movable check valve.
  • the pump is collapsible to a first, smaller-radius state in which the pump is implantable within a body of a patient via the catheter and expandable to a second, larger-radius state after implanting via the catheter to an operational position within the body of the patient.
  • the first movable check valve may be attached to the outer flexible conduit to form a sealed attachment therewith.
  • the heart assist system may further include an inner flexible conduit having a diameter less than the outer flexible conduit.
  • the first movable check valve may be attached to the inner flexible conduit at a position radially inward from the perimeter of the first movable check valve.
  • the first movable check valve may be attached to the outer flexible conduit to form a sealed attachment therewith and may be attached to the inner flexible conduit to form a sealed attachment therewith.
  • a method of assisting the function of the heart or circulation includes placing a heart assist system as described above in connection with a patient's circulatory system.
  • the pump is positioned within the ascending aorta with a distal end of the pump extending into the left ventricle.
  • a heart assist pump which is connectable to a catheter, includes an outer flexible conduit, a first movable check valve attached to the outer flexible conduit about the perimeter of the first movable check valve, and a first actuator operatively connected to the first movable check valve and configured to be connected to a drive system remote from the heart assist pump via the catheter to transfer linear motion from the drive system to the first movable check valve.
  • Tire heart assist pump is collapsible to a first, smaller-radius state in which the heart assist pump is implantable within a body of a patient via the catheter and expandable to a second, larger-radius state after implanting via the catheter to an operational position within the body of the patient.
  • the first movable check valve may be attached to the outer flexible conduit to form a sealed attachment therewith.
  • the heart assist pump may further include an inner flexible conduit having a diameter less than the outer flexible conduit.
  • the first movable check valve may be attached to the inner flexible conduit at a position radially inward from the perimeter of the first movable check valve.
  • the first movable check valve may be attached to the outer flexible conduit to form a sealed attachment therewith and may be attached to the inner flexible conduit to form a sealed attachment therewith.
  • a method of assisting the function of the heart or circulation includes placing a heart assist pump as described above in connection with a patient's circulatory system.
  • the pump is positioned within the ascending aorta with a distal end of the pump extending into the left ventricle.
  • circuitry includes, but are not limited to, hardware, firmware, software, or combinations of each to perform a function(s) or an action(s).
  • a circuit may include a software controlled microprocessor, discrete logic such as an application specific integrated circuit (ASIC), or other programmed logic device.
  • a circuit may also be fully embodied as software.
  • circuit is considered synonymous with “logic.”
  • logic includes, but is not limited to, hardware, firmware, software, or combinations of each to perform a function(s) or an action(s), or to cause a function or action from another component.
  • logic may include a software controlled microprocessor, discrete logic such as an application specific integrated circuit (ASIC), or other programmed logic device.
  • Logic may also be fully embodied as software.
  • processor includes, but is not limited to, one or more of virtually any number of processor systems or stand-alone processors, such as microprocessors, microcontrollers, central processing units (CPUs), and digital signal processors (DSPs), in any combination.
  • the processor may be associated with various other circuits that support operation of the processor, such as random access memory (RAM), read-only memory (ROM), programmable read-only memory (PROM), erasable programmable read only memory (EPROM), clocks, decoders, memory controllers, or interrupt controllers, etc.
  • RAM random access memory
  • ROM read-only memory
  • PROM programmable read-only memory
  • EPROM erasable programmable read only memory
  • clocks decoders
  • memory controllers or interrupt controllers, etc.
  • These support circuits may be internal or external to the processor or its associated electronic packaging.
  • the support circuits are in operative communication with the processor.
  • the support circuits are not necessarily shown separate from the processor in block diagrams or other drawings
  • controller includes, but is not limited to, any circuit or device that coordinates and controls the operation of one or more input and/or output devices.
  • a controller may, for example, include a device having one or more processors, microprocessors, or central processing units capable of being programmed to perform functions.
  • the term “software,” as used herein includes, but is not limited to, one or more computer readable or executable instructions that cause a computer or other electronic device to perform functions, actions, or behave in a desired manner.
  • the instructions may be embodied in various forms such as routines, algorithms, modules, or programs including separate applications or code from dynamically linked libraries.
  • Software may also be implemented in various forms such as a standalone program, a function call, a servlet, an applet, instructions stored in a memory, part of an operating system or other type of executable instructions. It will be appreciated by one of ordinary skill in the art that the form of software is dependent on, for example, requirements of a desired application, the environment it runs on, or the desires of a designer/programmer or the like.
  • the heart assist and pump devices, systems, and methods hereof achieve a number of desirable results in left ventricular assist.
  • the heart assist systems provide blood movement with less shear than currently available systems.
  • the pump systems hereof reduce shear by pushing blood without shearing it as rotary pumps do.
  • the heart assist system hereof may be temporarily or permanently implanted without major surgery.
  • Heart assist system hereof may, for example, be implanted without the requirement for opening the chest cavity.
  • the heart assist systems hereof may be used to move/pump blood in-series with the LV instead of pumping around and competing with the LV.
  • heart assist systems hereof include a heart assist pump which is remotely activated/driven via a drive system located outside the chest wall.
  • the pump can, for example, include one or more moving valves and may provide a solution for various shortcomings of currently available assist devices such as VADs.
  • a dual moving valve (that is, a two-moving- valve) pump is discussed as a representative example.
  • a single moving valve or more than two moving valves may be provided in various embodiments of a heart assist pump hereof.
  • inventions of the heart assist systems hereof include, but are not limited to, installing an assist device/VAD minimally invasively; pushing blood rather than slicing blood; having a blood pumping mechanism that will satisfy both short- and long-term needs; pumping blood in series with the left ventricle; and having an assist device mechanism that is failsafe.
  • embodiments of moving valve pumps hereof are catheter-based with a compressed diameter (for example, approximately 7 mm). Further, when located with a distal end in the LV, moving valve pumps hereof are deployable to a larger diameter (for example, approximately 16 mm or larger) while leaving space between the catheter-delivered pump and the aortic wall for blood to flow backwards into the coronary arteries.
  • the drive system (including, for example, a motor) may be positioned external to the rib cage and either outside the body for temporary use or subcutaneously for permanent use.
  • Linear actuators may be used to control valve position and velocity.
  • the pumps hereof pump blood by collapsing an annular shaped elastic chamber in the axial/linear direction.
  • two moving-valve controlled collapsing chambers may be employed in series which may, for example, be operated or of phase.
  • the two moving valves are operated approximately! 80 degrees (that is, within 5 degrees of 180 degrees) out of phase in a number of embodiments.
  • the cycling speed may be reduced or minimized by increasing/ maximizing the cross-sectional area of the moving valve(s).
  • a target flow rate for a heart assist device may, for example, be a blood flowrate produced by a normal heart, namely 5,000 milliliters (ml’s) or cubic centimeters (cc’s) per minute.
  • the stroke frequency for 5,000 cc per minute will be 5+ cycles per second.
  • the stroke frequency would have to double to 10 to 11 strokes per second. The preceding calculation neglects the possibility of backflow that will occur when the moving valve is returning to its most distal position. To the extent that backflow exists, the stroke frequency will need to be increased to maintain the targeted flowrate.
  • valve motion jerkiness is the opposite of smooth valve motion in which rapid changes in velocity and acceleration are absent.
  • the valve of a reciprocating, moving valve pump must travel forward, slow down, stop, move in reverse, stop and then move forward again.
  • jerkiness is at a minimum and the motion is not likely to be sensed by the patient.
  • Providing a plurality of (for example, two) valves results in additional smoothness.
  • valves may be controlled such that the two valves travel in generally equal and opposite directions, thereby balancing the motion (momentum) of the two valves.
  • having two (or more) valves sharing the pumping work will provide nearly continuous flow at a much lower cycling rate than the case of a single valve.
  • two moving valves are provided in series and are operated or cycled such that the valves are approximately 180 degrees out of phase as described above.
  • Moving valves in a pump including three moving valves may, for example, be cycled approximately 120 degrees out of phase.
  • the generally cylindrical wall of pump systems hereof is flexible in at least the axial direction.
  • blood shear can be greatly reduced, minimized or completely eliminated.
  • Moving valve pumps hereof will certainly have much less blood shear than the high speed (30,000 to 50,000 RPM) Archimedes screw type pumps.
  • valve perimeter or rim does not slide on/relative to the inside surface of its outside containment wall, tube, conduit or housing. Such sliding action will inevitably produce substantial blood shear and associated shear-induced blood damage.
  • extra material is provided in the length of the conduit to which the movable valve rim is attached (that is, in an axial direction, and between attachment points for such material) such that the reciprocal motion of the movable valve does not result is significant (or any) stretching of the material (for example, elongation of a polymer material) of the wall.
  • significant stretching refers to an extension strain of X% or more. Minimizing or eliminating such stretching assists in reducing or minimizing the force/energy required to move the valve(s).
  • the generally cylindrical conduit wall of assist systems or devices hereof is corrugated or has accordion-like folds therein to provide extra material between attachment points such that very little energy is required to extend the length of the conduit wall and the risk of failure as a result of fatigue is minimized or eliminated.
  • the drive system/methodology for providing remote motive power for two or more moving valves may, for example, include a single rotating motor and rotor placed outside the chest cavity.
  • a remote drive system may, for example, drive the moving valves of the pump (which may be positioned inside the aorta as described further below) using two linear actuators (for a dual valve pump) that are attached proximately to the motor’s rotor and distally to the valves.
  • Tire actuators could, for example, include linear actuators such as independent wires or tubes. If the actuators include tubes, one tube could be placed inside the other.
  • the actuator(s) could be a combination of a wire and a tube that would facilitate the wire/tube within a tube feature.
  • the valve actuators may be sufficiently laterally flexible to negotiate the curvature of the arterial tree but sufficiently axially/linearly stiff to efficiently transmit energy to the valves.
  • the ascending aorta is a thick-walled fibrous structure that can provide a mechanical ground for the contracting LV to push blood through its attached aortic valve.
  • a moving valve pump hereof can benefit from a mechanical ground attached to the ascending aortic wall to assure that the distal end of the moving valve pump may be stabilized inside the LV.
  • the cross-sectional area or CSA of the dual valve pump is smaller than the CSA of the ascending aorta so that during the LV’s diastolic or resting period, blood from the aorta can flow backwards and around the pump to supply blood to the LV’s coronary arteries.
  • the entrances for the two coronary arteries may be aside the aortic valve but effectively above the aortic valve.
  • a mechanical ground for the dual valve pump is provided by an expandable, open wire stent positioned between the moving valve pump and the inside wall of the ascending aorta. Coronary artery blood flow could then be provided through the open bare wire stent while the stent provides a mechanical ground for the moving valve pump.
  • Embodiments of a moving valve pump hereof may, for example, operate in two ways.
  • the pump can be operated to cycle continuously to minimize its cycle speed or it can be operated during systole only when the heart is contracting to provide pulsatile blood flow.
  • the assisted flow output from a moving valve pump hereof will depend on its cycle rate combined with its cross-sectional area or CSA. For a given desired flow assist rate, the needed flow rate will be inversely related to the pump’s effective CSA multiplied by its cycle rate.
  • one foil pump cycle results from one full rotation of the motor’s rotor driving the linear actuators for the valve(s).
  • An adjustment to the flow calculation may be made for that motion required to close the valves as well as for discounting a portion of the CSA used for the CSA overheads of, for example, a guidewire lumen, the blood sealing bellows sections defined by the valve positions, and the valve actuators in a number of embodiments as described forth below.
  • the CSA overhead or CSA discount may, for example, be approximately 20%.
  • Blood flow in rotary VADs is generally continuous and dependent on both pump pressure differential and cycle rate. This will not be true for moving valve pumps hereof because such pumps are essentially positive displacement pumps.
  • the CSA is the product of the 0.8 centimeter radius squared multiplied by 7i which is 2 cm 2 . Discounting for an overhead of 20% results in an effective CSA of 1.6 cm 2 .
  • the moving valve pump may, for example, include thromboresistant surfaces combined with some degree of anticoagulant medication.
  • thromboresistant surfaces available as coatings such as heparin, 2-methacryloyloxtethyl phosphorylcholine (MPC) or hyaluronic acid coatings.
  • Copolymers of polyurethane and silicon for example, copolymers of methylene diphenyl diisocyanate (MDI) based polyurethanes and hydroxyl-terminated polydimethyl siloxane
  • MDI methylene diphenyl diisocyanate
  • ElastEonTM available as ElastEonTM from, for example, RUA Biomaterials of Irvine, Ayrshire Scotland
  • Such polymers provide high mechanical performance while being non-thrombogenic, biostable, non-calcific, abrasion resistant and fatigue resistant.
  • Non-thrombogenic or thromboresistant properties may, for example, be important in managing the risk of embolic clots coming from the moving valve pump.
  • the moving valve(s) of the pumps hereof operate as check valve(s).
  • check valves allow flow in one direction but not, or minimally, in the opposite direction through the valve.
  • the valves hereof are desirably passive in a number of embodiments. In that regard, such valves require no energy to open or close other than energy harvested from the fluid flowing through the valve itself.
  • a closing element or elements is present that closes the valve in response to valve backflow. Many types of valve closing elements are known.
  • Representative examples include, but are not limited to, flexible cusps such as the three cusps of a natural aortic valve, flaps as described further below in a representative embodiment hereof, hinged element or doors that function similarly to flaps but include a combination of a flexible hinge and a rigid surface, and flexible membranes (for example, a conically shaped but flexible membrane). All such closure elements operate to close or open the valve’s CSA in response to the valve’s flow direction.
  • moving valves hereof minimize backflow closing volumes to improve forward stroke efficiency, minimize any blood shear causing obstructions, and maximize the valve’s cross-sectional area or CSA to operate near the minimum effective speed.
  • the remotely driven/actuated moving valve pumps hereof provide failsafe operation in the sense that, in the case of pump power loss, the heart will be able to pump blood through the pump hereof, although heart failure may return. Permanent VAD power loss is often fatal as a result of unrestricted backflow.
  • FIGS. 1A through 1C illustrate a representative embodiment of a dual valve pump 100 of a heart assist system 50 and 50a, respectively, located in ascending aorta 10 with the distal end or tip of pump 100 extending into left ventricle 20.
  • catheter portion 200 of pump 100 of dual valve heart assist system 50 exits the body from the left axillary region in the illustrated embodiment of FIG. 1A to interface with external motor drive system 300.
  • tire physician visualizes the left axillary artery.
  • a flexible guidewire 102 (see, FIGS. 2 A and 2B) having a diameter of, for example, 18 to 25 mils may first be inserted through an arteriotomy and threaded through the arterial tree and aortic valve into left ventricle 20. Dual valve pump 100 may then be threaded over guidewire 102 using the guidewire lumen 104 (see, FIGS. 2A and 2B) within pump 100.
  • a compression sleeve 106 is used to maintain pump 100 in a compressed state during insertion.
  • a moving valve pump hereof such as dual valve pump 100 may also be installed from the right side with a sub clavicular cutdown as illustrated in FIG. 1C using the analogous procedure except that the arterial tree pathway will include the innominate artery.
  • motor drive system 300a is miniaturized and encased in, for example, a titanium shell. An axillary incision is enlarged, and a subcutaneous pocket is created to house encased motor drive system 300a.
  • FIGS. 2 A and 2B illustrate pumping mechanism or pump 100 of dual valve heart assist system 50 and 50a.
  • FIG. 2 A illustrates pump 100 in a compressed state in which the compressed diameter may, for example, be between 5 and 10 mm.
  • Compression sleeve 106 holds valves 110, 110’ in the compressed state.
  • pump 100 expands/springs outwardly to, for example, a diameter of 15 to 20 mm.
  • Valves 110, 110’ may, for example, be formed of a polymeric material which is, for example, thermally formed in the uncompressed state such that valves 110, 110; are biased to the uncompressed state.
  • bare metal stent 108 which is positioned inside compression sleeve 106, will also expand/spring radially outwardly when compression sleeve 106 is withdrawn from pump 100.
  • the deployed diameter of stent 108 will become the width of ascending aorta 10 and deployed stent 108 will become mechanical ground for system 50, 50a.
  • a cylindrical chamber or basket or cage 130 (see FIG.1C) that is designed to reside in the LV.
  • Chamber 130 may, for example, be constructed from a soft polymer such as low durometer polyurethane.
  • the most distal portion of chamber 130 is perforated to allow blood intake when pumping.
  • a proximal portion of chamber 130 has a solid wall (that is, not perforated) that functions as a seal within the aortic valve.
  • two pumping chambers (as formed or defined by valves 110, 110’) reside in the space between two thin-walled, flexible elastic conduits or tubes 140 and 140a, both of which may be convoluted or accordion-like.
  • a function of inner tube 140a is to create a sealed, blood-free space of volume 145 for the valve actuators 150, 150’ and guidewire lumen wall 104.
  • Seals 148 may be provided to prevent blood from entering into the space around actuators 150, 150’.
  • Outer pumping chamber wall/flexible elastic tube 140 is sealed to a perimeter of each valve 110, 110’ to assist in assuring a pushing rather than sliding action on the blood as described above.
  • valve actuators 150 and 150’ in FIG. 2A are shown schematically as tubes, while valve actuators 150 and 150’ in FIG. 2B are shown schematically as wires .
  • B lood exits pump 100 via outlet ports or openings 160 formed in a proximal portion of flexible tube 140 as illustrated in FIG. 2B and 3 A.
  • the shaded ovals 148 in FIGS. 2 A and 2B function as connection nodes and seals.
  • Guidewire lumen wall 104 is shown in FIG. 2 A but, to avoid confusion, is not shown in FIG. 2B.
  • each of inner and outer walls, conduits, tubes or housings 140 and 140a can include extra material or slack in an axial direction such that the reciprocal motion of the movable valves does not result in significant (or any) stretching/elongation of the material forming the wall of the conduits.
  • such conduits may be corrugated or have accordion- like folds therein to provide extra material in an axial direction (between attachment points) such that very little energy is required to move valves 110 and 110’.
  • FIG 3 A illustrates an embodiment of a system and method that may be used to activate valve motion.
  • the proximal ends of the valve actuators 150 and 150’ are placed in operative connection with a crankshaft 400 via rotating bearings 404 positioned apart or spaced 180° around crankshaft 400.
  • Crankshaft 400 may, for example, include a centered axel 410 that may operatively connect to (for example, snap into an opening in) a rotor 310 of a DC torque motor 300 as illustrated in FIG. 3B.
  • rotating axle operatively connected to motor 300 may be connected with two equal and oppositely positioned drive arms.
  • Each drive arm may have an end including a rotating bearing that connects independently to one of linear actuators 150, 150’ to control the oscillating motion of each of two moving valves 110, 110’.
  • Bearings for example, miniature ball bearings
  • linear actuators 150, 150’ may also be used in connection with linear actuators 150, 150’ to, for example, reduce friction and associated frictional heating.
  • FIG. 4A is a sideview of an embodiment of a valve structure for valve 110 (which may be identical to valve 100’) showing five of eight struts 112 that each support valve flaps 114 as shown in FIG. 4B.
  • the valve structure may be micromachined or molded from a hard but bendable material such as high durometer polyurethane. Struts 112 may be compressed to the diameter of actuating rod 116, 116’ via which they connect to actuators 150, 150 in the embodiment illustrated for valve 110.
  • valve flaps 114 are generally triangularly shaped when in a closed position. Each flap 114 may, for example, be solvent bonded to the surface of strut 114 to which flap 114 is connected.
  • valve flaps 114 are oversized for the aperture space between stmts 112 and functionally close valve 100 (by closing ports between stmts 112) when they contact and overlap on the surfaces of adjacent stmts 112. Flaps 114 may, for example, be formed to be in a curved open state as illustrated in FIGS. 4 A and 4B and close (that is, by flexing to come into contact against an adjacent stmt 112) under the force exerted by blood upon flaps 114 when valve 110 is moved in a proximal direction to move blood.
  • FIG. 5 illustrates schematically the spatial relationship of dual valve pump 100, LV 20, aortic valve 12 and ascending aorta 10 in a representative position of an assist system of the device hereof.
  • Chamber/basket 130 extends into LV 20 and seals within aortic valve 12.
  • Bare wire stent 108 expands against the wall of ascending aorta 20.
  • the pumping portion of dual valve pump 100 (wherein, valves 110, 110’ are represented by a dual or double arrow) resides in ascending aorta 20.
  • drive catheter 200 for pump 100 has been introduced from the patient’s left axilla through left subclavian artery 30.
  • pump system 100 hereof may be in communicative/electrical connection with electronic circuitry 500 for power and control thereof.
  • Electronic circuitry 500 may be positioned external to the body, internal to the body, or be distributed in position depending upon the manner in which pump system 100 is deployed.
  • electronic circuitry 500 may, for example, include processor system 510 (which may, for example, include one or more processors and/or microprocessors) in operative connection with a memory system 520.
  • Memory system 520 may, for example, include software including one or more algorithms stored therein and executable by processor system 510 to operate as a control system or controller to control operation of pump system 100 (for example, of drive system 300, 300a of pump system 100).
  • Electronic circuitry 500 may further include a sensor system 530 in communicative connection with processor system 510 to measure data such as physiological data (for example, ECG data), data on the operation of pump system 100, and/or other data. Such data may, for example, be used in control of pump system 100 via, for example, feedback control as known in the control arts.
  • an input/output system 540 may be in operative connection with processor system 510 and memory system 510, for example, to acquire data (for example, signals from sensor system 530 and other sources) and/or to enable output of data/information.
  • a communication system 550 may be in communicative connection with processor system 510 for wired and/or wireless communication between various system components as well as to one or more communication devices positioned remote from pump system 100 and electronic circuitry 500.
  • a user interface system 560 as known in the computer arts may be in operative connection with processor system 510.
  • a power system 570 (for example, including a battery pack system, a transcutaneous energy transmission system (TETS) as described above, etc.) is in electrical connection with processor system 510 and other powered components of electronic circuitry 500 and pump system 100.
  • TETS transcutaneous energy transmission system

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mechanical Engineering (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Transplantation (AREA)
  • External Artificial Organs (AREA)
  • Prostheses (AREA)

Abstract

Un système d'assistance cardiaque comprend un cathéter et une pompe escamotable/expansible reliée à une extrémité distale du cathéter. La pompe comprend un conduit flexible externe, un premier clapet de non-retour mobile fixé au conduit flexible externe autour du périmètre du premier clapet de non-retour mobile, et un second clapet de non-retour mobile, espacé du premier clapet de non-retour mobile et en série avec celui-ci, fixé au conduit flexible externe autour du périmètre du second clapet de non-retour mobile. Un système d'entraînement positionné à distance est relié au cathéter. Un premier actionneur et un second actionneur sont reliés fonctionnellement au système d'entraînement pour transférer un mouvement linéaire du système d'entraînement au premier clapet de non-retour mobile et au second clapet de non-retour mobile, respectivement.
PCT/US2024/035655 2023-06-27 2024-06-26 Systèmes d'assistance cardiaque comprenant des pompes à sang à soupape mobile Ceased WO2025006632A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363510452P 2023-06-27 2023-06-27
US63/510,452 2023-06-27

Publications (2)

Publication Number Publication Date
WO2025006632A2 true WO2025006632A2 (fr) 2025-01-02
WO2025006632A3 WO2025006632A3 (fr) 2025-05-01

Family

ID=93940177

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2024/035655 Ceased WO2025006632A2 (fr) 2023-06-27 2024-06-26 Systèmes d'assistance cardiaque comprenant des pompes à sang à soupape mobile

Country Status (1)

Country Link
WO (1) WO2025006632A2 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE455164B (sv) * 1985-12-05 1988-06-27 Data Promeditech Inc Ab Pump for biologiska vetskor
US7371223B2 (en) * 2002-10-02 2008-05-13 Boston Scientific Scimed, Inc. Electroactive polymer actuated heart-lung bypass pumps
BR102016022713A2 (pt) * 2016-09-29 2018-05-02 Zammi Instrumental Ltda Membrana para câmara de circulação de fluidos, câmara e bomba para assistência circulatória artificial e sistema de bombeamento
EP3765110B1 (fr) * 2018-03-13 2022-04-06 Boston Scientific Scimed, Inc. Dispositif d'assistance circulatoire
US11839708B2 (en) * 2019-10-19 2023-12-12 SummaCor, Inc. Linear cardiac assist pulsatile pump

Also Published As

Publication number Publication date
WO2025006632A3 (fr) 2025-05-01

Similar Documents

Publication Publication Date Title
US11957891B2 (en) Percutaneous blood pump and introducer system
US12053623B2 (en) Modular mammalian body implantable fluid flow influencing device and related methods
US12343516B2 (en) Intracardiac percutaneous pump for circulatory support and related systems and methods
US9333284B2 (en) Heart assist device
US11058865B2 (en) Catheter pump
US10183104B2 (en) Modular implantable ventricular assist device
Reul et al. Blood pumps for circulatory support
EP0986409A1 (fr) Appareil d'assistance ventriculaire avec pompe a sang axiale a rotor ferme
EP2209508A1 (fr) Pompe sanguine pulsée
WO2021062566A1 (fr) Système de turbine modulaire pour circulation de fluide
US20250090830A1 (en) Percutaneous Endovascular Centrifugal Heart Pump and Method
Doost et al. Ventricular assist devices: current state and challenges
Frazier et al. Small pumps for ventricular assistance: progress in mechanical circulatory support
US20260069850A1 (en) Modular mammalian body implantable fluid flow influencing device and related methods
CN117083100B (zh) 具有内置压力感测器的心室辅助装置
CN117083102A (zh) 具无漏式主动脉接合器组件的血泵装置和装置植入方法
Moscato et al. Engineering and clinical considerations in rotary blood pumps

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE